Eye treatment

SEO Keywords

1. Anatomical Narrow Angle Treatment
2. Laser Peripheral Iridotomy Disparities
3. Ophthalmology Practice Patterns
4. Narrow Angle Glaucoma Care
5. Sociodemographic Factors in Eye Health

A groundbreaking investigation into the management of newly diagnosed anatomical narrow angles (ANA) in the United States has unearthed significant insights into the treatment patterns and sociodemographic disparities that exist in clinical care. The consequential study was recently published in the prestigious American Journal of Ophthalmology and is set to ignite conversation and hopefully, change, among clinicians and health policy makers.

Conducted by Kristy K. Yoo from the Keck School of Medicine at the University of Southern California, along with esteemed co-researchers Galo G. Apolo, Khristina K. Lung, Brian B. Toy, and Benjamin B. Xu, the study meticulously evaluated retrospective data of 263,422 patients diagnosed with ANA sourced from the Optum Clinformatics® Data Mart between 2007 and 2019. By restricting the focus to patients with fresh diagnoses of ANA – ensuring each had continuous enrollment for two years before diagnosis and one year after – researchers guaranteed a complete picture of treatment patterns unaffected by previous interventions.

DOI Information

The digital object identifier (DOI) for the study is 10.1016/j.ajo.2024.01.003, ensuring the article can be easily located for detailed review.

Main Findings

It was discovered that among 52,405 qualifying cases, a modest 27.7% of patients received laser peripheral iridotomy (LPI), only 13.9% were treated with IOP-lowering drops, and 15.1% underwent cataract surgery. Notably, the odds of receiving LPI were higher for Asian and Hispanic populations (odds ratio [OR] ≥1.16, p<0.001), particularly poignant given the serious nature of ANA, which can lead to vision-threatening angle-closure glaucoma if untreated.

However, the study unearthed a concerning disparity in cataract surgery rates: Hispanics were less likely to receive this treatment (OR=0.79, p<0.001) despite the potential vision-preserving benefits of the procedure. The mean number of eye care visits patients had, including the day of diagnosis, was 2.6±2.1 – with older patients and those undergoing treatment having higher rates of visits.

Interpretation of Data

The researchers interpret these numbers as indicative of a care paradigm where more than a quarter of newly diagnosed ANA patients undergo treatment with LPI. That racial minorities, while receiving ANA-specific treatments such as LPI and IOP-lowering medications at a higher rate, encounter lower instances of cataract surgery poses a conundrum and suggests that there may be underlying factors at play, like disparities in access to care or varying disease severities that necessitate different management strategies.

Moreover, the overall number of eye care visits could point towards underutilization of ophthalmology services post-diagnosis, which might affect the prognosis of individuals with ANA. Perhaps a deeper look into how eye care is accessed and followed up on could unveil further insights into this crucial healthcare concern.

Impact on Ophthalmology Practice and Future Directions

This seminal work by Yoo and team calls for the establishment of clearer practice guidelines in the care of patients with ANA to ensure uniformity and equity in treatment across demographics. The authors surmise that the racial differences uncovered in disease severity and management may reflect intrinsic biases in healthcare delivery or could be attributed to genetic variations that influence disease manifestations.

As such, the study beckons further research to parse out the causes of these disparities and demands action to develop universally accepted and effective clinical guidelines. This initiative would not only potentially streamline practice patterns but also mitigate sociodemographic disparities in ANA care.

References

1. Yoo, K. K., et al. (2024). Practice Patterns and Sociodemographic Disparities in the Clinical Care of Anatomical Narrow Angles in the United States. American Journal of Ophthalmology, [prenumbered], 1879-1891. https://doi.org/10.1016/j.ajo.2024.01.003

2. Tham, Y. C., et al. (2014). Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040: A Systematic Review and Meta-Analysis. Ophthalmology, 121(11), 2081–2090. doi:10.1016/j.ophtha.2014.05.013

3. Sun, X., et al. (2017). The Screening for Primary Angle Closure Glaucoma in the General Population: A Systematic Review. Clinical & Experimental Ophthalmology, 45(5), 461–468. doi:10.1111/ceo.12910

4. Friedman, D. S., et al. (2002). Prevalence of Open-angle Glaucoma among Adults in the United States. Archives of Ophthalmology, 120(6), 802–809. doi:10.1001/archopht.120.6.829

5. Quigley, H. A. (1996). Number of People with Glaucoma Worldwide. British Journal of Ophthalmology, 80(5), 389–393. doi:10.1136/bjo.80.5.389

Declaration of Competing Interest:
The authors assert that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

In conclusion, this critical research conducted by Yoo and colleagues raises awareness of the complexities inherent in the treatment of patients with ANA, highlighting both the progress made in care and the multifaceted nature of healthcare disparities. It ultimately serves as a call to action for the medical community to reevaluate current protocols and strive towards a future where access to and quality of eye care is uniform and impartial, regardless of a patient’s race or socioeconomic status.